NISCH and atherosclerosis: Pharmacological blockade using a selective I1R antagonist (AGN192403) recapitulated these protective effects, reducing immune activation, plaque complexity, necrotic cores, and atherosclerosis progression in multiple mouse models without altering cholesterol.